Validation of a Predictive Risk Equation for Type 2 Diabetes in Families With Risk
NCT01727349 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1035
Last updated 2021-05-11
Summary
Considering its epidemic-like development worldwide, associated with modifications in lifestyle, as well as its enormous social and economic weight, the prevention of type II diabetes is certain to be a central concern of health systems within the developed countries in the decades to come. However, while simple obesity concerns the entire population, type 2 diabetes affects only one sub-population at high genetic risk. To be effective and realistic in economic terms, efforts at prevention must be thus targeted towards these subjects at high risk. The key issue involves identifying such subjects early enough so that a strategy of effective prevention can be organized in good time.
Until now, efforts have been concentrated on individuals at risk for diabetes readily identifiable within the general population, typically subjects in the second half of adulthood, presenting abdominal obesity and mild abnormalities of blood sugar. Preventive lifestyle and dietary measures are proposed but are constrictive and difficult to maintain over time, and the results, although they may be significant, remain disappointing, with mere postponement of an outcome which at this stage appears inevitable. The reason is ascribable to excessively tardy intervention, when the pathogenic process has already been ongoing for some ten years and the endocrine function of the pancreas is probably already irreparably impaired.
The alternative thus is earlier intervention, in childhood, adolescence or early adulthood. The problem is to identify individuals at high risk of becoming diabetic at a time when they are presenting no simple clinical or laboratory abnormalities allowing easy diagnosis. The familial character of type 2 diabetes is now well established, and future diabetic subjects are themselves above all the children of diabetic subjects. However, the prevalence of the disease among the descendants of type 2 diabetic subjects is around 20-30% and predictive tools are needed to combat diabetes in these high-risk families.
We propose to create a risk equation using an algorithm to reliably predict children most likely to develop diabetes later in life.
The algorithm will include 3 classes of data:
* The genotype stemming from the genetic characterization of individuals and those their parents;
* Environmental data concerning childhood, especially eating habits and physical activity;
* Data of the mother who was eventually diabetic during pregnancy.
From a methodological standpoint, it would be rather difficult to take blood samples from children and wait some 50 years to determine whether or not they develop diabetes. To circumvent this difficulty, we will recruit subjects in families with a history of type II diabetes:
* Parents alive, including at least one type 2 diabetic subject
* Adult children (aged over 35 years), some of whom are already presenting type II diabetes, and healthy brothers and sisters, who form the control population. Test will be done to determine whether healthy subjects are really safe from the risk of diabetes (HbA1c measurement and glucose load test).
The Descendence study will include 500 families at risk involving about 3000 subjects (1000 subjects with diabetes and 2000 healthy subjects). It is expected to answer the following question: for a child born in such families at risk, what is the probability of developing diabetes later in life, so that early preventive action may be taken
Conditions
Interventions
- OTHER
-
HbA1c measurement
- OTHER
-
Oral Glucoce Tolerance Test
Oral Glucoce Tolerance Test
Sponsors & Collaborators
-
Centre d'Etudes et de Recherche pour l'Intensification du Traitement du Diabète
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-12-14
- Primary Completion
- 2020-11-24
- Completion
- 2020-11-24
Countries
- Belgium
- France
Study Locations
More Related Trials
-
Diabetes Prevention in Women With a Recent History of Gestational Diabetes (Focus Groups)
NCT01102530 ·Status: COMPLETED
-
Development and Validation of the Blood Glucose Measurement Device by Air Analysis Expired
NCT05207020 ·Status: COMPLETED ·Phase: NA
-
Real-Life Home Glucose Monitoring Over 14 Days in T2D Patients With Intensified Therapy Using Insulin Pump.
NCT03436212 ·Status: COMPLETED ·Phase: NA
-
Real-time Continuous Glucose Monitoring Compared With Intermittent Continuous Glucose Monitoring in People With Type 2 Diabetes Treated With Insulin.
NCT07308925 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Data Acquisition Study in Inadequately Balanced Patients With Type 2 Diabetes Mellitus
NCT04155996 ·Status: TERMINATED
-
Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 Diabetes
NCT00401622 ·Status: COMPLETED ·Phase: NA
-
Prospective Observational Study Assessing Treatment and Outcomes of Patients With Prediabetes
NCT01869101 ·Status: UNKNOWN
-
Tolerability, Acceptance, and Utility of Intermittent CGM Use in Youth With Prediabetes
NCT05505565 ·Status: COMPLETED ·Phase: NA
-
Blood Monitoring and Data Acquisition and Utilization in Patients With Type 2 Diabetes Treated With Insulin
NCT01175408 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring (CGM) With a Low Carbohydrate Diet to Reduce Weight in Patients With Pre-Diabetes
NCT03695913 ·Status: COMPLETED ·Phase: NA
-
Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe
NCT07233434 ·Status: RECRUITING ·Phase: NA
-
Real Time Continuous Glucose Monitoring System in T2DM With Pregnacy
NCT05947916 ·Status: UNKNOWN ·Phase: NA
-
Association Between CGM Metrics in Type 2 Diabetes Pregnancy and Perinatal Morbidity
NCT06892314 ·Status: COMPLETED
-
PRECISE: A Prospective, Multi-Center Evaluation of the Accuracy of a Novel Continuous Implanted Glucose Sensor
NCT02154126 ·Status: COMPLETED ·Phase: NA
-
Satisfaction of Hospitalized Diabetic Patients Using a Continuous Glucose Monitoring System
NCT03411460 ·Status: TERMINATED ·Phase: NA
-
CGM Use in Adults With Type 2 Diabetes on Basal Insulin
NCT05944432 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Impact of Self-Monitoring Blood Glucose Frequency on Glycemic Control in Patients With Type 2 Diabetes
NCT00202033 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes
NCT01741467 ·Status: COMPLETED ·Phase: NA
-
Continuous Glucose Monitoring in Women With Type 1 Diabetes in Pregnancy Trial
NCT01788527 ·Status: COMPLETED ·Phase: NA
-
Type 1 Diabetic Post Prandial Glycemia Evaluation Using an Algorithm
NCT05151770 ·Status: COMPLETED
-
Effect of the FreeStyle Libre 2 Flash Glucose Monitoring System on Hyperglycemia in People With T2 Diabetes
NCT04604093 ·Status: COMPLETED
-
Effect of the Use of Continuous Glucose Monitoring Versus Standard Glycemic Control in Hospitalized Patients with Type 2 Diabetes.
NCT06607224 ·Status: COMPLETED ·Phase: NA
-
Development of Continuous Glucose Monitoring System Cohort for Personalized Diabetes Prevention and Management Platform
NCT04369833 ·Status: COMPLETED
-
Effect of Switching From Intermittently Scanned to Real-time Continuous Glucose Monitoring on Diabetes Management in Adults With Type 2 Diabetes (Switch CGM T2D)
NCT06805786 ·Status: RECRUITING
-
The Next Generation Longitudinal Birth Cohort Diabetes Study
NCT04621396 ·Status: RECRUITING